人間の誘発性多能幹細胞におけるリング染色体の細胞自律的補正
Marina Bershteyn1, Yohei Hayashi2, Guillaume Desachy3
11] Institute for Human Genetics and Department of Pediatrics, University of California, San Francisco, California 94143, USA [2] Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, California 94143, USA [3].
Nature
|January 14, 2014
まとめ
細胞の再プログラミングは,新しい方法を提示します.
科学分野:
- 遺伝学と分子生物学について
- 発達生物学 発達生物学について
- 幹細胞生物学 幹細胞生物学
背景:
- リング染色体は,重度の先天性欠陥や発達上の問題に関連した構造的異常である.
- これらの異常は,多くの場合,複数の遺伝子に影響を及ぼし,治療戦略が欠如する大規模な削除を含みます.
- 細胞分裂中のリング染色体の不安定さは,低生存率のアヌプロイド細胞につながる.
研究 の 目的:
- 細胞の再プログラミング中のリング染色体の行動を調査する.
- 誘発性多能幹細胞 (iPSCs) がリング染色体疾患に対処する可能性を調査する.
- 染色体不安定性と数値制御の研究のためのモデルシステムを確立する.
主な方法:
- リング染色体と大きな欠損を持つ患者フィブロブラストから生成されたヒト誘発性多能幹細胞 (iPSCs).
- 再プログラムされた細胞の染色体行動と遺伝子構成を分析した.
- iPSCの特徴を特定するために,カリオタイプとUPD分析を用いた.
主要な成果:
- 再プログラムされたiPSCは,異常なリング染色体を自発的に失いました.
- 細胞は,野生型の同類体の補償的な単親分裂 (UPD) を通して遺伝的欠陥を修正した.
- アイソディソミーのカリオタイプ的に正常なiPSCは,アヌプロイド細胞に取って代わられ,競争に勝った.
結論:
- 細胞再プログラミングは,大きな欠損を持つ環染色体疾患の"染色体療法"の一形態として機能します.
- このプロセスは,元の染色体異常から解放された患者由来のiPSCを効率的に隔離します.
- この研究は,発達と病気に関連する染色体数制御メカニズムを調査するための処理可能なヒト細胞システムを提供します.
関連する概念動画
01:32Chromatin Modification in iPS Cells
1.5K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.5K
01:13Induced Pluripotent Stem Cells
22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
01:24Methods of Nuclear Reprogramming
1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
01:29Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K